Danish Health Care Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 21-12-2024
- Paid Up Capital ₹ 1.00 M
as on 21-12-2024
- Company Age 11 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.00 Cr
as on 21-12-2024
- Satisfied Charges ₹ 1.55 Cr
as on 21-12-2024
- Revenue 59.63%
(FY 2022)
- Profit 140.09%
(FY 2022)
- Ebitda 98.63%
(FY 2022)
- Net Worth 89.55%
(FY 2022)
- Total Assets 39.10%
(FY 2022)
About Danish Health Care
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹10.00 Cr. The company has closed loans amounting to ₹1.55 Cr, as per Ministry of Corporate Affairs (MCA) records.
Murtaza Barwahwala and Qasim Danish serve as directors at the Company.
- CIN/LLPIN
U24232MP2013PTC030065
- Company No.
030065
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Feb 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Ujjain, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Danish Health Care?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Murtaza Barwahwala  | Director | 15-Feb-2013 | Current |
| Qasim Danish | Director | 15-Feb-2013 | Current |
Financial Performance of Danish Health Care.
Danish Health Care Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 59.63% increase. The company also saw a substantial improvement in profitability, with a 140.09% increase in profit. The company's net worth Soared by an impressive increase of 89.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Danish Health Care?
In 2022, Danish Health Care had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 03 Oct 2022 | ₹5.00 Cr | Open |
Others Creation Date: 12 Sep 2022 | ₹5.00 Cr | Open |
Others Creation Date: 26 Aug 2013 | ₹1.55 Cr | Satisfied |
How Many Employees Work at Danish Health Care?
Danish Health Care has a workforce of 16 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Danish Health Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Danish Health Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
